GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » Net Margin %

SynBiotic SE (XTER:SBX) Net Margin % : -283.65% (As of Dec. 2022)


View and export this data going back to 2021. Start your Free Trial

What is SynBiotic SE Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. SynBiotic SE's Net Income for the six months ended in Dec. 2022 was €-23.08 Mil. SynBiotic SE's Revenue for the six months ended in Dec. 2022 was €8.14 Mil. Therefore, SynBiotic SE's net margin for the quarter that ended in Dec. 2022 was -283.65%.

The historical rank and industry rank for SynBiotic SE's Net Margin % or its related term are showing as below:


XTER:SBX's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 4.54
* Ranked among companies with meaningful Net Margin % only.

SynBiotic SE Net Margin % Historical Data

The historical data trend for SynBiotic SE's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynBiotic SE Net Margin % Chart

SynBiotic SE Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial - -16.16 -147.13 -298.33 -275.34

SynBiotic SE Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only -893.88 -142.86 -4,154.84 -283.65 -

Competitive Comparison of SynBiotic SE's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, SynBiotic SE's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SynBiotic SE's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SynBiotic SE's Net Margin % distribution charts can be found below:

* The bar in red indicates where SynBiotic SE's Net Margin % falls into.


;
;

SynBiotic SE Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

SynBiotic SE's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-10.631/3.861
=-275.34 %

SynBiotic SE's Net Margin for the quarter that ended in Dec. 2022 is calculated as

Net Margin=Net Income (Q: Dec. 2022 )/Revenue (Q: Dec. 2022 )
=-23.075/8.135
=-283.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SynBiotic SE  (XTER:SBX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


SynBiotic SE Net Margin % Related Terms

Thank you for viewing the detailed overview of SynBiotic SE's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


SynBiotic SE Business Description

Traded in Other Exchanges
N/A
Address
Barer Strasse 7, Munich, BY, DEU, 80333
SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.
Executives
Daniel Kruse Geschäftsführender Direktor

SynBiotic SE Headlines

No Headlines